ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Toxic neuropathy | 17.09.03.017; 12.03.01.055 | 0.000206% | | Not Available |
Vulvovaginal pain | 21.08.02.009 | 0.000309% | | |
Kounis syndrome | 02.02.02.020; 24.04.04.020; 10.01.03.037 | 0.000516% | | Not Available |
Acute kidney injury | 20.01.03.016 | - | - | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.000377% | | Not Available |
White matter lesion | 24.04.06.027; 17.11.01.009 | 0.000206% | | Not Available |
Drug reaction with eosinophilia and systemic symptoms | 23.03.05.005; 10.01.01.021 | 0.001547% | | Not Available |
Diffuse alopecia | 23.02.02.007 | 0.000412% | | Not Available |
Developmental hip dysplasia | 15.11.07.014; 03.11.07.014 | 0.000206% | | Not Available |
Candida infection | 11.03.03.021 | 0.000215% | | |
Aspergillus infection | 11.03.01.004 | 0.000081% | | Not Available |
Immune thrombocytopenic purpura | 10.04.01.008; 01.08.01.007 | 0.000206% | | Not Available |
Body temperature abnormal | 13.15.01.030 | 0.000206% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.000215% | | |
Abdominal mass | 07.01.01.003 | 0.000206% | | Not Available |
Abnormal loss of weight | 14.03.02.019 | 0.000206% | | Not Available |
Blood blister | 23.03.01.028; 12.01.06.013 | 0.000309% | | Not Available |
Blood corticosterone increased | 13.10.09.010 | 0.000516% | | Not Available |
Disseminated cryptococcosis | 11.03.04.004 | 0.000309% | | Not Available |
Lymphadenopathy mediastinal | 22.09.03.006; 01.09.01.025 | 0.000206% | | Not Available |
Peripheral T-cell lymphoma unspecified | 16.17.06.001; 01.11.06.001 | 0.000054% | | Not Available |
Pleocytosis | 17.02.05.059 | 0.000206% | | Not Available |
Pulmonary valve stenosis congenital | 03.07.05.016; 02.07.04.006 | 0.000516% | | Not Available |
Transposition of the great vessels | 24.03.03.042; 03.07.08.009; 02.08.03.005 | 0.000619% | | Not Available |
Tumour marker increased | 13.22.01.017 | 0.000412% | | Not Available |
Pulmonary cavitation | 22.01.02.022 | 0.000206% | | Not Available |
Acinetobacter infection | 11.02.01.033 | 0.000054% | | Not Available |
Genital erythema | 23.03.06.019; 21.10.01.015 | 0.000412% | | Not Available |
Palatal oedema | 07.05.04.008 | 0.001031% | | Not Available |
Mycotic endophthalmitis | 11.03.05.025; 06.04.05.029 | 0.000206% | | Not Available |